Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-01
2010-06-22
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07741281
ABSTRACT:
Macrocyclic peptides are disclosed having the general formula:wherein R′, R3, R3′, R4, R6, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
REFERENCES:
patent: 2005/0153877 (2005-07-01), Miao et al.
patent: 2006/0172950 (2006-08-01), Wang et al.
patent: 2006/0199773 (2006-09-01), Sausker et al.
patent: 2006/0257980 (2006-11-01), Li
patent: WO 98/17679 (1998-04-01), None
patent: WO 99/07733 (1999-02-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 02/060926 (2002-08-01), None
patent: WO 03/053349 (2003-07-01), None
patent: WO 03/064416 (2003-08-01), None
patent: WO 03/064455 (2003-08-01), None
patent: WO 03/064456 (2003-08-01), None
patent: WO 03/066103 (2003-08-01), None
patent: WO 03/099274 (2003-12-01), None
patent: WO 03/099316 (2003-12-01), None
patent: WO 2004/009121 (2004-01-01), None
patent: WO 2004/032827 (2004-04-01), None
patent: WO 2004/037855 (2004-05-01), None
patent: WO 2004/043339 (2004-05-01), None
patent: WO 2004/072243 (2004-08-01), None
patent: WO 2004/093798 (2004-11-01), None
patent: WO 2004/093915 (2004-11-01), None
patent: WO 2004/094452 (2004-11-01), None
patent: WO 2004/101602 (2004-11-01), None
patent: WO 2004/101605 (2004-11-01), None
patent: WO 2004/103996 (2004-12-01), None
patent: WO 2004/113365 (2004-12-01), None
patent: WO 2005/010029 (2005-02-01), None
patent: WO 2005/028501 (2005-03-01), None
patent: WO 2005/037214 (2005-04-01), None
patent: WO 2005/037860 (2005-04-01), None
patent: WO 2005/046712 (2005-05-01), None
patent: WO 2005/051410 (2005-06-01), None
patent: WO 2005/051980 (2005-06-01), None
patent: WO 2005/054430 (2005-06-01), None
patent: WO 2005/070955 (2005-08-01), None
patent: WO 2005/073216 (2005-08-01), None
patent: WO 2005/095403 (2005-10-01), None
patent: WO 2005/116054 (2005-12-01), None
patent: WO 2006/000085 (2006-01-01), None
patent: WO 2006/007700 (2006-01-01), None
patent: WO 2006/007708 (2006-01-01), None
patent: WO 2006/016930 (2006-02-01), None
patent: WO 2006/020276 (2006-02-01), None
patent: WO 2006/026352 (2006-03-01), None
patent: WO 2006/033878 (2006-03-01), None
patent: WO 2006/043145 (2006-04-01), None
patent: WO 2006/086381 (2006-08-01), None
patent: WO 2006/096652 (2006-09-01), None
patent: WO 2006/119061 (2006-11-01), None
patent: WO 2006/122188 (2006-11-01), None
patent: WO 2006/130552 (2006-12-01), None
patent: WO 2006/130553 (2006-12-01), None
patent: WO 2006/130554 (2006-12-01), None
patent: WO 2006/130626 (2006-12-01), None
patent: WO 2006/130627 (2006-12-01), None
patent: WO 2006/130666 (2006-12-01), None
patent: WO 2006/130686 (2006-12-01), None
patent: WO 2006/130687 (2006-12-01), None
patent: WO 2007/001406 (2007-01-01), None
patent: WO 2007/008657 (2007-01-01), None
patent: WO 2007/009227 (2007-01-01), None
patent: WO 2007/014918 (2007-02-01), None
patent: WO 2007/014919 (2007-02-01), None
patent: WO 2007/014920 (2007-02-01), None
patent: WO 2007/014921 (2007-02-01), None
patent: WO 2007/014922 (2007-02-01), None
patent: WO 2007/014923 (2007-02-01), None
patent: WO 2007/014924 (2007-02-01), None
patent: WO 2007/014925 (2007-02-01), None
patent: WO 2007/014926 (2007-02-01), None
patent: WO 2007/014927 (2007-02-01), None
patent: WO 2007/015787 (2007-02-01), None
patent: WO 2007/015824 (2007-02-01), None
patent: WO 2007/015855 (2007-02-01), None
patent: WO 2007/016441 (2007-02-01), None
patent: WO 2007/016476 (2007-02-01), None
patent: WO 2007/017144 (2007-02-01), None
U.S. Appl. No. 11/546,505, filed Oct. 11, 2006, Carini, et al.
Lauer G. M. et al., “Hepatitis C Virus Infection,” New England Journal of Medicine, vol. 345 No. 1, pp. 41-52, (2001).
Poupart, M.-A. et al., “Solid-Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease,” The Journal of Organic Chemistry, vol. 66 No. 14, pp. 4743-4751, (2001).
Campbell Jeffrey Allen
D'Andrea Stanley
Good Andrew Charles
McPhee Fiona
Scola Paul Michael
Bristol--Myers Squibb Company
Heard Thomas S
Mingo Pamela A.
Tsang Cecilia
Volles Warren K.
LandOfFree
Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4157926